Multi-factors assessment in COVID-19 patients: Fungal infection, ABO blood group, and age factors

Author:

Al-Janabi Uday H K1

Affiliation:

1. Department of Microbiology, College of Medicine, University of Babylon, Hilla, Iraq

Abstract

Abstract Background: The coronavirus disease 2019 (COVID-19) pandemic is a serious and global public health concern. Severity of infection, fatality rates, and treatment responses across different countries, age groups, and demographic groups suggest that the nature of infection is diverse. Objectives: Evaluation of several factors: presence of fungal infection, analysis of ABO blood group distribution pattern, age distribution, percentage of death, and well-being outcome for each blood group patient. Materials and Methods: Data collection included the presence of fungal infection and measurement of its percentage. Classification of patients according to ABO blood group and measuring their mean age distribution and death-wellbeing outcome. Results: This study showed the presence of 5% of fungal infection among the patients. This study showed that the distribution of ABO blood group in 90 patients with COVID-19 was as follows: 38.9% (35), 28.9% (26), 26.7% (24), and 5.6% (5) for O, A, B, and AB blood group patients respectively. The analysis of variance study revealed no significant difference in age distribution between different ABO blood group patients. The outcome for these patients was that 35.6% died and 64.4% recovered. A higher percentage of deaths occurred in patients with B blood group (approximately 45.8%, 11 out of 24 patients) and a lower percentage of deaths noted in patients with A blood group (about 34.6%, 9 out of 26 patients). The higher percentage of recovery was among O blood group patients with 71.4% (25 out of 35 patients). The lower percentage of recovery was among B blood group patients with 54.2% (13 out of 24 patients). Conclusion: This study concluded that despite the higher percentage of COVID-19 infections in patients with O blood group, its high good outcome is promising. On the other hand, this point must be taken into consideration while planning vaccinations, since patients with B blood group have a high percentage of deaths and lower percentage of recovery.

Publisher

Medknow

Reference16 articles.

1. Covid-19, history and modern laboratory diagnostic techniques: A rapid review;Jebur;J Pharm Negative Res,2022

2. COVID-19 worldwide: We need precise data by age group and sex urgently;Bhopal;BMJ,2020

3. Factors associated with COVID-19-related death using OpenSAFELY;Williamson;Nature,2020

4. Does pulmonary aspergillosis complicate COVID-19? External icon;Beer;Crit Care Exp,2020

5. Antifungal susceptibility patterns of Aspergillus species isolated from patients with pulmonary diseases in Iraq;Al-Charrakh;J Appl Pharm Sci,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3